Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 10/20 | 0.51 |
| ▸ | HRH1 | P35367 | 1/20 | 0.51 |
| ▸ | KCNA5 | P22460 | 3/20 | 0.50 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.50 |
| ▸ | BCHE | P06276 | 3/20 | 0.48 |
| ▸ | ACHE | P22303 | 3/20 | 0.48 |
| ▸ | DRD2 | P14416 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4743300 | 0.93 | HRH3 (0.57) | HRH3HRH1HRH4BCHEACHE | |
| SCHEMBL4745332 | 0.93 | HRH3 (0.57) | HRH3HRH1KCNA5HRH4DRD2 | |
| SCHEMBL4745363 | 0.84 | HRH3 (0.56) | HRH3KCNA5MEN1KMT2A | |
| SCHEMBL4746202 | 0.84 | MAOB (0.54) | — | |
| SCHEMBL4746694 | 0.83 | LSS (0.55) | HRH3HRH1DRD2MEN1KMT2A | |
| SCHEMBL4746681 | 0.83 | HRH3 (0.46) | HRH3HRH1HRH4DRD2MEN1 | |
| SCHEMBL4747562 | 0.83 | HRH3 (0.55) | HRH3HRH1KCNA5HRH4DRD2 | |
| SCHEMBL4743813 | 0.83 | HRH3 (0.55) | HRH3HRH1HRH4DRD2MEN1 | |
| SCHEMBL4746206 | 0.83 | HRH3 (0.57) | HRH3MEN1KMT2A | |
| SCHEMBL4745346 | 0.83 | HRH3 (0.51) | HRH3HRH1KCNA5HRH4BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008107320-A1 | PIPERIDINE AND PIPERAZINE DERIVATIVES USED AS ANTI-NEOPLASIC AGENTS OR CELL PROLIFERATION INHIBITORS | CEREP (FR) | 2008-09-12 | — | — | WO | disclosed |